- Category
- Medium (2022-23)
- Udyam number
- UDYAM-MH-19-0122113

About Aglowmed Limited
Data last updated:
Aglowmed Limited is a public limited company based in Patna, Bihar, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 07 November 1983 and has been in existence for over 43 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24232BR1983PLC001901. Its GSTIN is 10AABCA9519L1ZR (Bihar). The company holds 22 GST registrations, of which 12 are active.
The company has an authorised share capital of ₹4.5 Cr and a paid-up capital of ₹2.96 Cr. It was formerly known as Aglowmed Private Limited. It is led by directors including Ashok Sharma (Managing Director) and Praveen Sharma.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 271 Patliputra Colony, Patna, Bihar, India – 800013.
As per the financials filed for FY 2025, the company reported a revenue of ₹139.55 Cr, a growth of 11% compared to the previous year. For the same year it recorded a net profit of ₹1.1 Cr (net margin 0.8%) and EBITDA of ₹5.78 Cr (EBITDA margin 4.1%). Revenue has grown at a compounded annual rate (CAGR) of 10% over three years and 11% over five years.
The company has about 1,047 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Aglowmed. As per MCA filings, the company has open charges of ₹42 Cr and satisfied charges of ₹94.02 Cr on record. Court records list 315 cases involving the company, including 180 filed by the company and 135 filed against it; 72 cases are pending. The company has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.76 Cr; the latest was in March 2024. Its 8 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 4 smaller; the largest is Sovereign Pharma Private Limited with revenue of ₹142.09 Cr.
Aglowmed Limited is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0122113). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website aglowmed.com.
Company details
CIN history
Aglowmed has one previous CIN (Corporate Identification Number): U24230BR1983PTC001901. The current CIN is U24232BR1983PLC001901, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24232BR1983PLC001901 | Current |
| U24230BR1983PTC001901 | Previous |
Recognitions & Rankings of Aglowmed
Contact details
Aglowmed Limited's registered office is in Patna, Bihar. Its website is aglowmed.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address271 Patliputra Colony, Patna, Bihar, India – 800013
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Aglowmed Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Aglowmed operates one associated brand: Aglowmed. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Specializes in manufacturing and distributing pharmaceutical products and services. | aglowmed.com |
Business activity
The main business activity of Aglowmed is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Aglowmed Limited, buy the company report.
Financials of Aglowmed Limited
FY 2025 filings availableAglowmed Limited reported revenue of ₹139.55 Cr (up 11% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 11% over five years, including 11% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.78 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹1.1 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.1% | ||||
| Net Profit Margin | 0.8% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Aglowmed Limited, buy the company report.
Board of directors of Aglowmed Limited
Aglowmed has 6 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Praveen Sharma | Director | 10 Sep 2004 | 22 Years 1 Months | Current |
| Gyan Prakash | Additional Director | 03 Oct 2023 | 3 Years 0 Months | Current |
| Aihshan Sharma | Director | 09 Sep 2009 | 17 Years 1 Months | Current |
| Ashok Sharma Also directs: Cura Farma Private Limited, Soter Propkem Pvt Ltd, Kunal Propkem Private Limited and 2 more | Managing Director | 25 Aug 2003 | 23 Years 1 Months | Current |
| Abhishek Kumar Also directs: Abdico LLP | Additional Director | 15 Jan 2024 | 2 Years 9 Months | Current |
| Abeejayh Ashok Kumar Sharma Also directs: Cura Farma Private Limited, Aglow Impex Private Limited | Director | 21 Sep 2017 | 9 Years 1 Months | Current |
Peer comparison
Aglowmed Limited is compared with the 8 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sovereign Pharma Private Limited | ₹142.09 Cr (FY 2025) | 15.0% | Mumbai, Maharashtra, India | |||
| Svizera Labs Private Limited | ₹142.05 Cr (FY 2022) | 7.0% | Thane, Maharashtra, India | |||
| Ratnatris Pharmaceuticals Private Limited | ₹141.71 Cr (FY 2025) | 35.0% | Ahmedabad, Gujarat, India | |||
| Lyka Labs Limited | ₹140.73 Cr (FY 2025) | 25.0% | Ankleshwar, Gujarat, India | |||
| Aglowmed Limitedthis company | ₹139.55 Cr (FY 2025) | ₹1.1 Cr | 0.8% | 11.0% | 1,047 | Patna, Bihar, India |
| Jackson Laboratories Private Limited | ₹139.35 Cr (FY 2024) | 14.0% | Punjab, India | |||
| Ontop Pharmaceuticals Private Limited | ₹138.93 Cr (FY 2024) | 4.0% | Hosur Road, Bangalore, Karnataka, India | |||
| Sundyota Numandis Probioceuticals Private Limited | ₹138.84 Cr (FY 2025) | 24.0% | Ahmedabad, Gujarat, India | |||
| M.M. Remedies Private Limited | ₹137.33 Cr (FY 2025) | 10.0% | Llucknow, Uttar Pradesh, India |
To see the full peer comparison of Aglowmed Limited, buy the company report.
Auditor
Aglowmed Limited is audited by A A Pathak and Company for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A A Pathak and Company | FY 2024 | 019448C |
Shareholding
The shareholding of Aglowmed Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Aglowmed Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 24 Oct 2025 | 101185120 | Hdfc Bank Limited | ₹22.65 Lakh | Open | |
| 29 Jan 2024 | 100925086 | Hdfc Bank Limited | ₹1.19 Cr | Open | |
| 30 Apr 2022 | 100585698 | Others | ₹12 Cr | Open | |
| 16 Jul 2020 | 100397630 | Others | ₹3.75 Cr | Open | |
| 14 May 2019 | 100261894 | Others | ₹5.33 Cr | Open |
To see the full charge records of Aglowmed Limited, buy the company report.
Total charge records: 43 View all charges
Deals & funding
Aglowmed Limited has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.76 Cr; the latest was in March 2024.
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2024 | Funding round | ₹45 Lakh | Investors: 3 individuals |
| Feb 2022 | Funding round | ₹51.4 Lakh | Investors: 4 individuals |
| Mar 2013 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
| Jul 2011 | Funding round | ₹19.6 Lakh | Investors: 2 individuals |
| Mar 2007 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: an individual |
To see the full deal history of Aglowmed Limited, buy the company report.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Aglowmed Limited has 315 court cases on record: 180 filed by Aglowmed, 135 filed against it. 72 cases are pending and 243 are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 212 | 101 | 53 |
| High courts | 97 | 31 | 19 |
| Supreme Court | 5 | 2 | 0 |
| NCLT | 1 | 1 | 0 |
Cases on record (5 of 315)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court | Interim or miscellaneous application | Filed by the company against Patanjali Ayurved Ltd | Pending |
| High Court, MAHARASHTRA | Court case (COMIP) | Filed by the company against Oscar Remedies Pvt Ltd | Pending |
| Bombay High Court | Arbitration matter | Filed against the company by Aglow Pharmaceuticals Pvt. Ltd. | Pending |
| District court, South West, Delhi | Commercial suit | Filed against the company by M/S Shikha Packaging (India) Pvt Ltd, Through A.R. Arjun Singh | Disposed |
| District court, Solan, Himachal Pradesh | Court case (Suit For Recovery) | Filed against the company by M/S Morepen Laboratories Ltd. | Disposed |
To see the full case history of Aglowmed Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Aglowmed Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Aglowmed Limited has a workforce of 1,047 employees on its EPFO records as of Feb 18, 2025, across 2 active EPFO establishments.
GST
Aglowmed has 22 GST registrations: 12 active and 10 cancelled or inactive. The first 4 active GSTINs are listed below.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AABCA9519L1ZR | Bihar | Active | 01 Jul 2017 |
| 05AABCA9519L2ZH | Uttarakhand | Active | 01 Jul 2017 |
| 08AABCA9519L1ZC | Rajasthan | Active | 01 Jul 2017 |
| 09AABCA9519L1ZA | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Aglowmed Limited, buy the company report.
Recent activity
Aglowmed Limited has 8 board changes on record since 2003: 6 appointments and 2 cessations. The latest: Tanuja Sharma ceased to be Director on 19 May 2024.
84 earlier events are in the company report.
Frequently asked questions
Aglowmed is an active public limited company based in Patna, Bihar, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 07 November 1983 (43+ years old) and is registered under CIN U24232BR1983PLC001901.
Aglowmed has 6 current directors:
- Ashok Sharma - Managing Director
- Praveen Sharma - Director
- Gyan Prakash - Additional Director
- Aihshan Sharma - Director
- Abhishek Kumar - Additional Director
- Abeejayh Ashok Kumar Sharma - Director
The latest financial statements of Aglowmed on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Aglowmed is 10AABCA9519L1ZR, registered in Bihar. The company has 22 GST registrations in all, of which 12 are active and 10 are cancelled or inactive. Other active GSTINs include 05AABCA9519L2ZH (Uttarakhand), 08AABCA9519L1ZC (Rajasthan), 09AABCA9519L1ZA (Uttar Pradesh).
The CIN (Corporate Identification Number) of Aglowmed is U24232BR1983PLC001901. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Aglowmed has 315 court cases on record: 180 filed by the company and 135 filed against it. 72 are pending. Most are in the district courts.
Aglowmed was incorporated on 07 November 1983, making it 43+ years old. It is registered with the Registrar of Companies, Patna.
Aglowmed has 6 deals on record (4 funding rounds, 2 secondary share transfers), with disclosed funding of ₹1.76 Cr; the latest was in March 2024.
The peers of Aglowmed by revenue are Sovereign Pharma Private Limited, Svizera Labs Private Limited, Ratnatris Pharmaceuticals Private Limited, Lyka Labs Limited, Jackson Laboratories Private Limited and 3 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Tanuja Sharma ceased to be Director on 19 May 2024. Abhishek Kumar was appointed as Additional Director on 15 Jan 2024. Gyan Prakash was appointed as Additional Director on 03 Oct 2023. Aglowmed has 8 board changes on record in total.
Yes, Aglowmed is registered as a medium enterprise under Udyam registration (number: UDYAM-MH-19-0122113).